Paper40652138
Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study.
Marco G and 11 others. Eur Arch Otorhinolaryngol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study. Papers, record 40652138. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40652138
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Efficacy of Dupilumab in the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP): a multicentric real-life study.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal, Humanized | Major topic |
| Nasal Polyps | Major topic |
| Rhinosinusitis | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Chronic Disease | |
| Eosinophils | |
| Follow-Up Studies | |
| Immunoglobulin E | |
| Quality of Life | |
| Treatment Outcome |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21605125 | Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. | Allergy | 2011 | https://conductscience.org/library/papers/21605125 | PubMed |
| 2 | 38762844 | Efficacy and safety of dupilumab in the treatment of CRSwNP in the real-life setting: a review of the literature. | Eur Arch Otorhinolaryngol | 2024 | https://conductscience.org/library/papers/38762844 | PubMed |
| 3 | 37234094 | Real-world evidence for the effectiveness and safety of dupilumab in patients with CRSwNP after 1 year of therapy. | World Allergy Organ J | 2023 | https://conductscience.org/library/papers/37234094 | PubMed |
| 4 | 37111387 | Effectiveness and Safety Profile of Dupilumab in Chronic Rhinosinusitis with Nasal Polyps: Real-Life Data in Tertiary Care. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37111387 | PubMed |
| 5 | 32644117 | Contemporary Classification of Chronic Rhinosinusitis Beyond Polyps vs No Polyps: A Review. | JAMA Otolaryngol Head Neck Surg | 2020 | https://conductscience.org/library/papers/32644117 | PubMed |
| 6 | 37632705 | Influence of Prior Endoscopic Sinus Surgery Extent on Dupilumab Effectiveness in CRSwNP Patients. | Laryngoscope | 2024 | https://conductscience.org/library/papers/37632705 | PubMed |
| 7 | 35468866 | Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps. | J Otolaryngol Head Neck Surg | 2022 | https://conductscience.org/library/papers/35468866 | PubMed |
| 8 | 17084217 | Rhinosinusitis: developing guidance for clinical trials. | J Allergy Clin Immunol | 2006 | https://conductscience.org/library/papers/17084217 | PubMed |
| 9 | 22616073 | Prevalence of chronic rhinosinusitis in Sao Paulo. | Rhinology | 2012 | https://conductscience.org/library/papers/22616073 | PubMed |
| 10 | 35490414 | High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients. | Clin Exp Allergy | 2023 | https://conductscience.org/library/papers/35490414 | PubMed |
| 11 | 8140385 | Staging in rhinosinusitus. | Rhinology | 1993 | https://conductscience.org/library/papers/8140385 | PubMed |
| 12 | 36999780 | EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. | Rhinology | 2023 | https://conductscience.org/library/papers/36999780 | PubMed |
| 13 | 37543087 | Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab: Real-World Use and Outcomes. | J Allergy Clin Immunol Pract | 2023 | https://conductscience.org/library/papers/37543087 | PubMed |
| 14 | 3327855 | First complete description of the aspirin idiosyncrasy-asthma-nasal polyposis syndrome (plus urticaria)--1922 (with a note on aspirin desensitization). By F. Widal, P. Abrami, J. Lermoyez. | J Asthma | 1987 | https://conductscience.org/library/papers/3327855 | PubMed |
| 15 | 32077450 | European Position Paper on Rhinosinusitis and Nasal Polyps 2020. | Rhinology | 2020 | https://conductscience.org/library/papers/32077450 | PubMed |
| 16 | 26302727 | Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis. | Allergy Rhinol (Providence) | 2015 | https://conductscience.org/library/papers/26302727 | PubMed |
| 17 | 37674253 | The "real life" efficacy of dupilumab is independent of initial polyp size and concomitant steroids in CRSwNP. | J Otolaryngol Head Neck Surg | 2023 | https://conductscience.org/library/papers/37674253 | PubMed |
| 18 | 19405090 | Genetic polymorphisms in chronic hyperplastic sinusitis with nasal polyposis. | Laryngoscope | 2009 | https://conductscience.org/library/papers/19405090 | PubMed |
| 19 | 36946589 | Dupilumab for chronic rhinosinusitis with nasal polyps: real-life retrospective 12-month effectiveness data. | Rhinology | 2023 | https://conductscience.org/library/papers/36946589 | PubMed |
| 20 | 27393770 | Chronic Rhinosinusitis with Nasal Polyps. | J Allergy Clin Immunol Pract | 2016 | https://conductscience.org/library/papers/27393770 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964453 | Chronic Rhinosinusitis with Nasal Polyps: T-Cell Dysregulation and Regulatory T-Cell Dysfunction. | Curr Otorhinolaryngol Rep | 2026 | https://conductscience.org/library/papers/42964453 | PubMed |
| 42783669 | Does Patient-Reported Olfactory Improvement Correlate with Quality of Life and Polyp Size Reduction in Patients with CRSwNP Treated with Dupilumab? | Medicines (Basel) | 2026 | https://conductscience.org/library/papers/42783669 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40652138
GET https://conductscience.org/api/papers/v1/40652138/references?page=2